Market Tracker

02/24 5:16pm ET

Heron Therapeutics Inc (NASDAQ:HRTX)

13.90
Delayed Data
As of Feb 24
 +0.15 / +1.09%
Today’s Change
12.21
Today|||52-Week Range
25.46
+6.11%
Year-to-Date
No recent news for Heron Therapeutics Inc.

Today’s Trading

Previous close13.75
Today’s open14.30
Day’s range13.80 - 14.75
Volume1,649,416
Average volume (3 months)858,395
Market cap$744.7M
Dividend yield--
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)-2.79%
Earnings growth (this year)-53.02%
Earnings growth (next 5 years)-19.63%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.25

Competitors

 Today’s
change
Today’s
% change
ADROAduro Biotech Inc+0.20+1.79%
PGNXProgenics Pharmaceut...+0.12+1.17%
VSARVersartis Inc+1.20+5.69%
CLLSCellectis SA-0.74-3.56%
Data as of 4:00pm ET, 02/24/2017

Financials

Next reporting dateMay 11, 2017
EPS forecast (this quarter)-$0.98
Annual revenue (last year)$0.00
Annual profit (last year)-$97.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Barry D. Quart
President, Director &
Chief Commercial Officer
Robert H. Rosen
Corporate headquarters
Redwood City, California

Forecasts